Home | Contact | Sitemap

Clinical experience of BD and COVID-19

This page aims to collect clinical experience of BD and COVID-19. Each individual case is obviously different, but previous experience is always worth taking into account.

Please send case reports, however brief, to Dorian Haskard at d.haskard@imperial.ac.uk. Submissions will be reviewed within ISBD prior to inclusion on this page. 

"So far, we have not seen any evidence regarding the influence of immunosuppressive drugs on coronavirus infection. No uveitis visiting my department reported coronavirus infection and we have not heard coronavirus infected patients from other departments complain suffering from vision loss, thus no change of the treatment." - verbatim report from an Ophthalmologist in China 

20th April 2020 - Professor Jan van Laar reports from Rotterdam :  A 21 year old female was admitted with COVID-19 pneumonia. She had originally presented aged 8 with fever and oral aphthous ulcers. Later on she developed vaginal ulcers,  pustules and  neurological symptoms, and also severe condylomata and warts on the hands. She has long been treated with prednisone and Remsima six-weekly (anti-TNF alpha). She mentioned that she easily acquires upper respiratory infections, presumably viral. She did not have any known risk factors for COVID-19 complications such as cardiovascular disease or obesity. She was in hospital for 7 days and recovered fully after antibiotics and oxygen supply by nasal canula. There was no clinical evidence of thrombosis.


Does anybody have more patients to share?








LookUs & Online Makale Home | Contact | Sitemap